News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Eli Lilly's Phase 3 trial shows retatrutide 12 mg delivered an average 28.3% body-weight reduction in the 80-week TRIUMPH-1 study.
  • Rising jet-fuel costs tied to the Middle East conflict are causing airlines to delay aircraft option exercises and raising insolvency risks, IATA and Embraer warn.
  • The U.S. is considering using frozen Iranian assets to fund Gulf infrastructure rebuilding after recent regional conflict.
  • Large credit managers are buying AI-linked debt structured to withstand potential credit strain from heavy corporate AI and data-center investment.
  • Southwest outlines product and network changes ahead of the 737 MAX 7's expected 2027 entry, including Starlink Wi‑Fi and upgraded premium seating.
  • White House AI adviser Sriram Krishnan will step down at the end of June and transition to an outside advisory role.

Latest Articles

NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions

NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions

NewAmsterdam Pharma announced multiple presentations at the National Lipid Association 2026 Scientific Sessions showcasing data on obicetrapib, their novel oral low-dose CETP inhibitor for hypercholesterolemia treatment. The presentations cover efficacy, safety, and potential cardiovascular benefits based on extensive Phase 2 and 3 clinical trials.…

WTW receives DFSA licence approval to operate investment business in Dubai International Financial Centre (DIFC)

WTW receives DFSA licence approval to operate investment business in Dubai International Financial Centre (DIFC)

WTW (NASDAQ: WTW), a global advisory and solutions firm, has received approval from the Dubai Financial Services Authority to operate as WTW Investments (DIFC) Limited in Dubai International Financial Centre. This licence enables WTW to offer regulated investment advisory services and fund solutions locally, marking a strategic expansion in the gro…

Geneva Objects to U.S. Forced-Labour Findings, Braces for Higher Duties

Geneva Objects to U.S. Forced-Labour Findings, Braces for Higher Duties

The Swiss economy ministry dismissed conclusions from a U.S. probe into how countries handle imports made with forced labour, rejecting recommendations that Switzerland faces higher tariffs. The U.S. Trade Representative has proposed new duties of 10% or 12.5% on goods from 60 economies to address alleged failures to curb trade in forced-labour pro…

Morgan Stanley Panel Sees Room to Grow for India’s Data Center Sector

Morgan Stanley Panel Sees Room to Grow for India’s Data Center Sector

A Morgan Stanley-hosted panel featuring leaders from Mindspace REIT, CapitaLand India Trust and Invest India concluded that India’s data center industry has significant runway for expansion but faces infrastructure constraints. With current capacity at about 1.4GW - roughly 1W per person - India trails China and the United States on a per-capita ba…

Raymond James Sees Upside in Lumber Stocks as Supply Cuts Tighten Markets

Raymond James Sees Upside in Lumber Stocks as Supply Cuts Tighten Markets

Raymond James says lumber equities are trading near multi-cycle lows at about 0.5 price-to-book after 15 quarters of housing weakness, and its supply-demand model anticipates tightening fundamentals driven by reduced European and Canadian shipments. The firm highlights select producers and distributors as potential beneficiaries of a recovery and q…

Prosecutors Find No Grounds to Overturn Contested Presidential Pardon in Italy

Prosecutors Find No Grounds to Overturn Contested Presidential Pardon in Italy

Italian prosecutors in Milan concluded an investigation into a presidential pardon granted to a former showgirl connected to late Prime Minister Silvio Berlusconi, finding no evidence to challenge the clemency. Authorities verified the legality of an adoption central to the pardon request and confirmed the adopted child's serious medical needs and …

India Greenlights Rs100 Billion Oil-Market Support to Stabilize Jet Fuel; Goldman Sees Short-Term Relief for Carriers

India Greenlights Rs100 Billion Oil-Market Support to Stabilize Jet Fuel; Goldman Sees Short-Term Relief for Carriers

India's Union Cabinet approved up to Rs100 billion in budgetary support to Oil Marketing Companies to stabilize aviation turbine fuel (ATF) prices for scheduled carriers on domestic and international routes. Goldman Sachs estimates the relief could cover between two and five months of fuel support depending on the price metric used, and notes the g…

Morgan Stanley Lowers Panasonic Rating After AI-Fueled Rally Narrows Upside

Morgan Stanley Lowers Panasonic Rating After AI-Fueled Rally Narrows Upside

Morgan Stanley reduced its recommendation on Panasonic Holdings to Equal-Weight from Overweight, saying the company's recent surge tied to AI infrastructure demand has diminished potential upside. The firm simultaneously lifted its price target to 3,900 yen from 3,000 yen and upgraded earnings forecasts while moving to a price-to-earnings valuation…

Morgan Stanley Raises ASML Price Target, Citing Stronger EUV Shipment Outlook

Morgan Stanley Raises ASML Price Target, Citing Stronger EUV Shipment Outlook

Morgan Stanley increased its price target on ASML Holding NV to €1,660 from €1,400 and maintained an overweight rating after interpreting comments from the company’s April annual general meeting as evidence of firmer near-term extreme ultraviolet (EUV) shipment capacity. The bank raised its unit shipment forecasts for 2027 and 2028, adjusted its va…

EU Faces Risk of Up to 1.3 Million Job Losses as Energy Costs Rise

EU Faces Risk of Up to 1.3 Million Job Losses as Energy Costs Rise

The European Commission warns that a surge in energy prices tied to the U.S.-Iran conflict could put as many as 1.3 million jobs at risk across the EU this year, concentrated in energy-intensive manufacturing and related sectors. The automotive industry is expected to suffer most, while households on lower incomes will face higher transport fuel co…

European Parliament to Make Qwant Default Search Engine on Edge and Firefox

European Parliament to Make Qwant Default Search Engine on Edge and Firefox

The European Parliament will set Qwant as the default search engine on its Microsoft Edge and Mozilla Firefox browsers from June 4, 2026, a step officials describe as intended to curb reliance on non-EU digital tools and to promote European, privacy-focused services. The European Commission will later unveil additional measures targeting chips, clo…

Trump Says He Cursed at Netanyahu During Call to Press for Ceasefire

Trump Says He Cursed at Netanyahu During Call to Press for Ceasefire

President Donald Trump acknowledged using expletives in a phone call with Israeli Prime Minister Benjamin Netanyahu as he urged an end to hostilities between Israel and Lebanon and sought to preserve negotiations with Iran. The call came after Tehran threatened to halt talks with the United States and to tighten maritime restrictions in the Strait …

Roku at 100M Homes: Underappreciated Ad Engine with Room to Run

Roku at 100M Homes: Underappreciated Ad Engine with Room to Run

Roku has cleared a key scale milestone - more than 100 million streaming households - and is turning that reach into accelerating platform revenue and free cash flow. The business mix is shifting from hardware to higher-margin ads and subscriptions; given improving profitability, robust FCF, and a still-conservative runway for ad monetization, I re…

Redemptions at Cliffwater Send Shockwaves Through Alternative-asset Stocks

Redemptions at Cliffwater Send Shockwaves Through Alternative-asset Stocks

Shares of large alternative asset managers tumbled after Cliffwater's $31 billion non-traded business development company reported 17% redemption requests in its May 2-29 tender window, up from 14% in February. The fund kept its 5% redemption threshold and said it has liquidity to meet those thresholds for about 12 months. Analysts warn the sector'…

Palvella Therapeutics Announces Completion of FDA Pre-NDA Meeting for QTORIN™ Rapamycin in Microcystic Lymphatic Malformations

Palvella Therapeutics Announces Completion of FDA Pre-NDA Meeting for QTORIN™ Rapamycin in Microcystic Lymphatic Malformations

Palvella Therapeutics has completed a pre-New Drug Application meeting with the FDA for its investigational drug QTORIN™ rapamycin, aimed at treating microcystic lymphatic malformations, a serious and chronic vascular malformation with no current FDA-approved treatment. The company remains on track to submit its NDA in the second half of 2026 and p…

TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)

TG Therapeutics Announces Positive Results from Phase 1 Trial Evaluating Subcutaneous BRIUMVI® (ublituximab-xiiy)

TG Therapeutics announced favorable Phase 1 trial results for their high-concentration subcutaneous formulation of BRIUMVI (ublituximab-xiiy), showing good tolerability, sustained drug exposure, and comparable biological activity versus intravenous administration. The data bolster confidence in the ongoing Phase 3 trial evaluating quarterly subcuta…

Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)

Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1)

Dyne Therapeutics has completed enrollment of 71 participants in the registrational expansion cohort of its Phase 1/2 ACHIEVE trial evaluating z-basivarsen (DYNE-101) for treatment of myotonic dystrophy type 1 (DM1). Topline data are anticipated in Q1 2027, supporting a potential U.S. Accelerated Approval submission by Q3 2027 and possible launch i…